Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
AEON Biopharma, Inc. (AEON) had Return on Equity of 67.49% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-37.14M |
|
-- |
|
-- |
|
$5.51M |
|
$-5.51M |
|
$-31.63M |
|
$-37.14M |
|
$-37.14M |
|
$-37.14M |
|
$-37.14M |
|
$-37.14M |
|
$-37.14M |
|
$-5.51M |
|
$-5.49M |
|
9.92M |
|
9.92M |
|
$-5.24 |
|
$-5.24 |
|
| Balance Sheet Financials | |
$3.40M |
|
$0.16M |
|
$2.16M |
|
$5.56M |
|
$6.90M |
|
$34.60M |
|
$53.69M |
|
$60.59M |
|
$-55.03M |
|
$-55.03M |
|
$-55.03M |
|
12.11M |
|
| Cash Flow Statement Financials | |
$-17.31M |
|
$-0.00M |
|
$20.30M |
|
$0.01M |
|
$3.01M |
|
$2.99M |
|
$5.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.49 |
|
-- |
|
-- |
|
-1.69 |
|
-0.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
67.49% |
67.49% |
|
-667.93% |
|
181.80% |
|
$-4.55 |
|
$-1.74 |
|
$-1.74 |
|